Ready-to-use therapeutic food with elevated n-3 polyunsaturated fatty acid content, with or without fish oil, to treat severe acute malnutrition: a randomized controlled trial

Kelsey D J Jones, Rehema Ali, Maureen A Khasira, Dennis Odera, Annette L West, Grielof Koster, Peter Akomo, Alison W A Talbert, Victoria M Goss, Moses Ngari, Johnstone Thitiri, Said Ndoro, Miguel A Garcia Knight, Kenneth Omollo, Anne Ndungu, Musa M Mulongo, Paluku Bahwere, Greg Fegan, John O Warner, Anthony D Postle, Steve Collins, Philip C Calder, James A Berkley, Kelsey D J Jones, Rehema Ali, Maureen A Khasira, Dennis Odera, Annette L West, Grielof Koster, Peter Akomo, Alison W A Talbert, Victoria M Goss, Moses Ngari, Johnstone Thitiri, Said Ndoro, Miguel A Garcia Knight, Kenneth Omollo, Anne Ndungu, Musa M Mulongo, Paluku Bahwere, Greg Fegan, John O Warner, Anthony D Postle, Steve Collins, Philip C Calder, James A Berkley

Abstract

Background: Ready-to-use therapeutic foods (RUTF) are lipid-based pastes widely used in the treatment of acute malnutrition. Current specifications for RUTF permit a high n-6 polyunsaturated fatty acid (PUFA) content and low n-3 PUFA, with no stipulated requirements for preformed long-chain n-3 PUFA. The objective of this study was to develop an RUTF with elevated short-chain n-3 PUFA and measure its impact, with and without fish oil supplementation, on children's PUFA status during treatment of severe acute malnutrition.

Methods: This randomized controlled trial in children with severe acute malnutrition in rural Kenya included 60 children aged 6 to 50 months who were randomized to receive i) RUTF with standard composition; ii) RUTF with elevated short chain n-3 PUFA; or iii) RUTF with elevated short chain n-3 PUFA plus fish oil capsules. Participants were followed-up for 3 months. The primary outcome was erythrocyte PUFA composition.

Results: Erythrocyte docosahexaenoic acid (DHA) content declined from baseline in the two arms not receiving fish oil. Erythrocyte long-chain n-3 PUFA content following treatment was significantly higher for participants in the arm receiving fish oil than for those in the arms receiving RUTF with elevated short chain n-3 PUFA or standard RUTF alone: 3 months after enrollment, DHA content was 6.3% (interquartile range 6.0-7.3), 4.5% (3.9-4.9), and 3.9% (2.4-5.7) of total erythrocyte fatty acids (P <0.001), respectively, while eicosapentaenoic acid (EPA) content was 2.0% (1.5-2.6), 0.7% (0.6-0.8), and 0.4% (0.3-0.5) (P <0.001). RUTF with elevated short chain n-3 PUFA and fish oil capsules were acceptable to participants and carers, and there were no significant differences in safety outcomes.

Conclusions: PUFA requirements of children with SAM are not met by current formulations of RUTF, or by an RUTF with elevated short-chain n-3 PUFA without additional preformed long-chain n-3 PUFA. Clinical and growth implications of revised formulations need to be addressed in large clinical trials.

Trial registration: Clinicaltrials.gov NCT01593969. Registered 4 May 2012.

Figures

Figure 1
Figure 1
Trial flow diagram.
Figure 2
Figure 2
Erythrocyte fatty acid composition. Median and interquartile ranges shown for the three arms at baseline, day 28, and day 84. Graphs show (clockwise from top left) DHA, EPA, AA, n-6:n-3 ratio in LC-PUFA, and total LC-PUFA (n-6 and n-3). For between-arm comparisons (ANOVA) at each time point: *P ≤0.05; **P ≤0.01; ***P ≤0.001. For within-arm comparison (sign test) to baseline values: † P ≤0.05. LC indicates species with carbon chain >18.
Figure 3
Figure 3
Effect modification of baseline PUFA status on EPA and DHA enrichment in erythrocytes. (A) Erythrocyte DHA and EPA between both arms without fish oil (S-RUTF and F-RUTF) compared to FFO-RUTF. Participants are stratified on the basis of their baseline DHA or EPA values. Low indicates equal to or below the median, and high indicates above the median. *P ≤0.05; **P ≤0.01; ***P ≤0.001 (by sign test). (B) Change in erythrocyte DHA or EPA from baseline to day 84 plotted against baseline DHA or EPA. Regression lines are colored the same as corresponding group symbols, black regression line is for S-RUTF and F-RUTF combined. P value is for effect modification across the three arms as described in the text.

References

    1. Black RE, Victora CG, Walker SP, Bhutta ZA, Christian P, de Onis M, et al. Maternal and child undernutrition and overweight in low-income and middle-income countries. Lancet. 2013;382:427–51. doi: 10.1016/S0140-6736(13)60937-X.
    1. Briend A, Myatt M, Dent N, Brown R. Putting kwashiorkor on the map. CMAM Forum 2013. .
    1. Black RE, Allen LH, Bhutta ZA, Caulfield LE, de Onis M, Ezzati M, et al. Maternal and child undernutrition: global and regional exposures and health consequences. Lancet. 2008;371:243–60. doi: 10.1016/S0140-6736(07)61690-0.
    1. Rytter MJ, Kolte L, Briend A, Friis H, Christensen VB. The immune system in children with malnutrition–a systematic review. PLoS One. 2014;9:e105017. doi: 10.1371/journal.pone.0105017.
    1. Bejon P, Mohammed S, Mwangi I, Atkinson SH, Osier F, Peshu N, et al. Fraction of all hospital admissions and deaths attributable to malnutrition among children in rural Kenya. Am J Clin Nutr. 2008;88:1626–31. doi: 10.3945/ajcn.2008.26510.
    1. World Health Organization, World Food Programme, United Nations System Standing Committee on Nutrition, United Nations Children’s Fund. Community-based management of severe acute malnutrition: a joint statement. Geneva: WHO; 2007. .
    1. United Nations Development Programme – Inter-Agency Procurement Support Office. Emergency relief items – compendium of generic specifications, volume 1. Copenhagen: UNDP; 1995.
    1. UNICEF. Supply Catalogue. 2014. .
    1. Calder PC. n-3 fatty acids, inflammation and immunity: new mechanisms to explain old actions. Proc Nutr Soc. 2013;72:326–36. doi: 10.1017/S0029665113001031.
    1. Calder PC. Very long chain omega-3 (n-3) fatty acids and human health. Eur J Lipid Sci Technol. 2014;116:1280–300. doi: 10.1002/ejlt.201400025.
    1. Kenya Open Data. Poverty rate by district. .
    1. Nackers F, Broillet F, Oumarou D, Djibo A, Gaboulaud V, Guerin PJ, et al. Effectiveness of ready-to-use therapeutic food compared to a corn/soy-blend-based pre-mix for the treatment of childhood moderate acute malnutrition in Niger. J Trop Pediatr. 2010;56:407–13. doi: 10.1093/tropej/fmq019.
    1. Food and Agriculture Organization of the United Nations. Fats and fatty acids in human nutrition: report of an expert consultation, FAO Food and Nutrition Paper, vol. 91. Rome: FAO; 2010.
    1. Thienprasert A, Samuhaseneetoo S, Popplestone K, West AL, Miles EA, Calder PC. Fish oil n-3 polyunsaturated fatty acids selectively affect plasma cytokines and decrease illness in Thai schoolchildren: a randomized, double-blind, placebo-controlled intervention trial. J Pediatr. 2009;154:391–5. doi: 10.1016/j.jpeds.2008.09.014.
    1. Ryan P. RALLOC: Stata module to design randomized controlled trials. EconPapers. 2011. .
    1. Bligh EG, Dyer WJ. A rapid method of total lipid extraction and purification. Can J Biochem Physiol. 1959;37:911–7. doi: 10.1139/o59-099.
    1. Browning LM, Walker CG, Mander AP, West AL, Madden J, Gambell JM, et al. Incorporation of eicosapentaenoic and docosahexaenoic acids into lipid pools when given as supplements providing doses equivalent to typical intakes of oily fish. Am J Clin Nutr. 2012;96:748–58. doi: 10.3945/ajcn.112.041343.
    1. Sewell GW, Hannun YA, Han X, Koster G, Bielawski J, Goss V, et al. Lipidomic profiling in Crohn’s disease: abnormalities in phosphatidylinositols, with preservation of ceramide, phosphatidylcholine and phosphatidylserine composition. Int J Biochem Cell Biol. 2012;44:1839–46. doi: 10.1016/j.biocel.2012.06.016.
    1. Postle AD, Henderson NG, Koster G, Clark HW, Hunt AN. Analysis of lung surfactant phosphatidylcholine metabolism in transgenic mice using stable isotopes. Chem Phys Lipids. 2011;164:549–55. doi: 10.1016/j.chemphyslip.2011.04.004.
    1. Dondorp AM, Angus BJ, Chotivanich K, Silamut K, Ruangveerayuth R, Hardeman MR, et al. Red blood cell deformability as a predictor of anemia in severe falciparum malaria. Am J Trop Med Hyg. 1999;60:733–7.
    1. World Health Organisation. The WHO Child Growth Standards. 2006. .
    1. Maitland K, Berkley JA, Shebbe M, Peshu N, English M, Newton CR. Children with severe malnutrition: can those at highest risk of death be identified with the WHO protocol? PLoS Med. 2006;3:e500. doi: 10.1371/journal.pmed.0030500.
    1. Moisi JC, Gatakaa H, Berkley JA, Maitland K, Mturi N, Newton CR, et al. Excess child mortality after discharge from hospital in Kilifi, Kenya: a retrospective cohort analysis. Bull World Health Organ. 2011;89:725–32. doi: 10.2471/BLT.11.089235.
    1. Kerac M, Bunn J, Chagaluka G, Bahwere P, Tomkins A, Collins S, et al. Follow-up of post-discharge growth and mortality after treatment for severe acute malnutrition (FuSAM study): a prospective cohort study. PLoS One. 2014;9:e96030. doi: 10.1371/journal.pone.0096030.
    1. Chisti MJ, Graham SM, Duke T, Ahmed T, Faruque AS, Ashraf H, et al. Post-discharge mortality in children with severe malnutrition and pneumonia in bangladesh. PLoS One. 2014;9:e107663. doi: 10.1371/journal.pone.0107663.
    1. Koletzko B, Lien E, Agostoni C, Bohles H, Campoy C, Cetin I, et al. The roles of long-chain polyunsaturated fatty acids in pregnancy, lactation and infancy: review of current knowledge and consensus recommendations. J Perinat Med. 2008;36:5–14.
    1. Carlson SE. Early determinants of development: a lipid perspective. Am J Clin Nutr. 2009;89:1523S–9. doi: 10.3945/ajcn.2009.27113G.
    1. Grantham-McGregor S. A review of studies of the effect of severe malnutrition on mental development. J Nutr. 1995;125:2233S–8.
    1. UNICEF. Ready-to-use therapeutic food for children with severe acute malnutrition. Position Paper. UNICEF, 2013. []
    1. Makhoul Z, Kristal AR, Gulati R, Luick B, Bersamin A, Boyer B, et al. Associations of very high intakes of eicosapentaenoic and docosahexaenoic acids with biomarkers of chronic disease risk among Yup’ik Eskimos. Am J Clin Nutr. 2010;91:777–85. doi: 10.3945/ajcn.2009.28820.
    1. Glaser C, Lattka E, Rzehak P, Steer C, Koletzko B. Genetic variation in polyunsaturated fatty acid metabolism and its potential relevance for human development and health. Matern Child Nutr. 2011;7:27–40. doi: 10.1111/j.1740-8709.2011.00319.x.
    1. Brenna JT, Salem N, Jr, Sinclair AJ, Cunnane SC. Alpha-Linolenic acid supplementation and conversion to n-3 long-chain polyunsaturated fatty acids in humans. Prostaglandins Leukot Essent Fatty Acids. 2009;80:85–91. doi: 10.1016/j.plefa.2009.01.004.
    1. Brenna JT, Carlson SE. Docosahexaenoic acid and human brain development: Evidence that a dietary supply is needed for optimal development. J Hum Evol. 2014;77:99–106. doi: 10.1016/j.jhevol.2014.02.017.
    1. Grindel A, Staps F, Kuhnt K. Cheek cell fatty acids reflect n-3 PUFA in blood fractions during linseed oil supplementation: a controlled human intervention study. Lipids Health Dis. 2013;12:173. doi: 10.1186/1476-511X-12-173.
    1. Gibson RA, Neumann MA, Lien EL, Boyd KA, Tu WC. Docosahexaenoic acid synthesis from alpha-linolenic acid is inhibited by diets high in polyunsaturated fatty acids. Prostaglandins Leukot Essent Fatty Acids. 2013;88:139–46. doi: 10.1016/j.plefa.2012.04.003.
    1. Gregory MK, Gibson RA, Cook-Johnson RJ, Cleland LG, James MJ. Elongase reactions as control points in long-chain polyunsaturated fatty acid synthesis. PLoS One. 2011;6:e29662. doi: 10.1371/journal.pone.0029662.
    1. Carlson SE, Werkman SH, Peeples JM, Cooke RJ, Tolley EA. Arachidonic acid status correlates with first year growth in preterm infants. Proc Natl Acad Sci U S A. 1993;90:1073–7. doi: 10.1073/pnas.90.3.1073.
    1. Gibson RA, Muhlhausler B, Makrides M. Conversion of linoleic acid and alpha-linolenic acid to long-chain polyunsaturated fatty acids (LCPUFAs), with a focus on pregnancy, lactation and the first 2 years of life. Matern Child Nutr. 2011;7:17–26. doi: 10.1111/j.1740-8709.2011.00299.x.
    1. Clark KJ, Makrides M, Neumann MA, Gibson RA. Determination of the optimal ratio of linoleic acid to alpha-linolenic acid in infant formulas. J Pediatr. 1992;120:S151–8. doi: 10.1016/S0022-3476(05)81250-8.
    1. Hsieh JC, Liu L, Zeilani M, Ickes S, Trehan I, Maleta K, et al. High oleic ready-to-use therapeutic food maintains docosahexaenoic acid status in severe malnutrition: a randomized, blinded trial. J Pediatr Gastroenterol Nutr. 2015 [epublished ahead of print].
    1. Taha AY, Cheon Y, Faurot KF, Macintosh B, Majchrzak-Hong SF, Mann JD, et al. Dietary omega-6 fatty acid lowering increases bioavailability of omega-3 polyunsaturated fatty acids in human plasma lipid pools. Prostaglandins Leukot Essent Fatty Acids. 2014;90:151–7. doi: 10.1016/j.plefa.2014.02.003.
    1. Liou YA, King DJ, Zibrik D, Innis SM. Decreasing linoleic acid with constant alpha-linolenic acid in dietary fats increases (n-3) eicosapentaenoic acid in plasma phospholipids in healthy men. J Nutr. 2007;137:945–52.
    1. von Schacky C. Omega-3 fatty Acids in cardiovascular disease - An uphill battle. Prostaglandins Leukot Essent Fatty Acids. 2014. [In press]
    1. McNamara RK. Evaluation of docosahexaenoic acid deficiency as a preventable risk factor for recurrent affective disorders: current status, future directions, and dietary recommendations. Prostaglandins Leukot Essent Fatty Acids. 2009;81:223–31. doi: 10.1016/j.plefa.2009.05.017.
    1. Luxwolda MF, Kuipers RS, Sango WS, Kwesigabo G, Dijck-Brouwer DA, Muskiet FA. A maternal erythrocyte DHA content of approximately 6 g% is the DHA status at which intrauterine DHA biomagnifications turns into bioattenuation and postnatal infant DHA equilibrium is reached. Eur J Nutr. 2012;51:665–75. doi: 10.1007/s00394-011-0245-9.
    1. Houssaini FZ, Foulon T, Iraqi MR, Payen N, Groslambert P. Lipids, lipoproteins, and fatty acids during infantile marasmus in the Fes area of Morocco. Biochem Pharmacol. 1999;53:278–83.
    1. Koletzko B, Abiodun PO, Laryea MD, Bremer HJ. Fatty acid composition of plasma lipids in Nigerian children with protein-energy malnutrition. Eur J Pediatr. 1986;145:109–15. doi: 10.1007/BF00441868.
    1. Smit EN, Dijkstra JM, Schnater TA, Seerat E, Muskiet FA, Boersma ER. Effects of malnutrition on the erythrocyte fatty acid composition and plasma vitamin E levels of Pakistani children. Acta Paediatr. 1997;86:690–5. doi: 10.1111/j.1651-2227.1997.tb08569.x.
    1. Leichsenring M, Sutterlin N, Less S, Baumann K, Anninos A, Becker K. Polyunsaturated fatty acids in erythrocyte and plasma lipids of children with severe protein-energy malnutrition. Acta Paediatr. 1995;84:516–20. doi: 10.1111/j.1651-2227.1995.tb13685.x.
    1. Wolff JA, Margolis S, Bujdoso-Wolff K, Matusick E, MacLean WC., Jr Plasma and red blood cell fatty acid composition in children with protein-calorie malnutrition. Pediatr Res. 1984;18:162–7. doi: 10.1203/00006450-198402000-00010.
    1. Holman RT, Johnson SB, Mercuri O, Itarte HJ, Rodrigo MA, De Tomas ME. Essential fatty acid deficiency in malnourished children. Am J Clin Nutr. 1981;34:1534–9.
    1. Vajreswari A, Narayanareddy K, Rao PS. Fatty acid composition of erythrocyte membrane lipid obtained from children suffering from kwashiorkor and marasmus. Metab Clin Exp. 1990;39:779–82. doi: 10.1016/0026-0495(90)90118-V.
    1. Franco VH, Hotta JK, Jorge SM, dos Santos JE. Plasma fatty acids in children with grade III protein-energy malnutrition in its different clinical forms: marasmus, marasmic kwashiorkor, and kwashiorkor. J Trop Pediatr. 1999;45:71–5. doi: 10.1093/tropej/45.2.71.
    1. Lauritzen L, Carlson SE. Maternal fatty acid status during pregnancy and lactation and relation to newborn and infant status. Matern Child Nutr. 2011;7:41–58. doi: 10.1111/j.1740-8709.2011.00303.x.
    1. Brenna JT, Varamini B, Jensen RG, Diersen-Schade DA, Boettcher JA, Arterburn LM. Docosahexaenoic and arachidonic acid concentrations in human breast milk worldwide. Am J Clin Nutr. 2007;85:1457–64.
    1. Michaelsen KF, Dewey KG, Perez-Exposito AB, Nurhasan M, Lauritzen L, Roos N. Food sources and intake of n-6 and n-3 fatty acids in low-income countries with emphasis on infants, young children (6–24 months), and pregnant and lactating women. Matern Child Nutr. 2011;7:124–40. doi: 10.1111/j.1740-8709.2011.00302.x.
    1. Prentice AM, Paul AA. Fat and energy needs of children in developing countries. Am J Clin Nutr. 2000;72:1253S–65.
    1. Smit EN, Oelen EA, Seerat E, Boersma ER, Muskiet FA. Fish oil supplementation improves docosahexaenoic acid status of malnourished infants. Arch Dis Child. 2000;82:366–9. doi: 10.1136/adc.82.5.366.
    1. van der Merwe LF, Moore SE, Fulford AJ, Halliday KE, Drammeh S, Young S, et al. Long-chain PUFA supplementation in rural African infants: a randomized controlled trial of effects on gut integrity, growth, and cognitive development. Am J Clin Nutr. 2013;97:45–57. doi: 10.3945/ajcn.112.042267.
    1. Jones KD, Hunten-Kirsch B, Laving AM, Munyi CW, Ngari M, Mikusa J, et al. Mesalazine in the initial management of severely acutely malnourished children with environmental enteric dysfunction: a pilot randomized controlled trial. BMC Med. 2014;12:133. doi: 10.1186/s12916-014-0133-2.

Source: PubMed

赞助者和合作者

医疗条件

药物干预

3
订阅